76
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Use of a Long-Acting Opioid Microsphere Formulation to Overcome Difficulties in Swallowing Pain Medication

, & ORCID Icon
Pages 955-960 | Published online: 06 May 2020

References

  • Ballantyne JC. Opioids for the treatment of chronic pain: mistakes made, lessons learned, and future directions. Anesth Analg. 2017;125(5):1769–1778. doi:10.1213/ANE.0000000000002500
  • Schiele JT, Quinzler R, Klimm HD, Pruszydlo MG, Haefeli WE. Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms. Eur J Clin Pharmacol. 2013;69(4):937–948. doi:10.1007/s00228-012-1417-0
  • Pergolizzi JV Jr, Taylor R Jr, Nalamachu S, et al. Challenges of treating patients with chronic pain with dysphagia (CPD): physician and patient perspectives. Curr Med Res Opin. 2014;30(2):191–202. doi:10.1185/03007995.2013.854197
  • Llorca PM. Discussion of prevalence and management of discomfort when swallowing pills: orodispersible tablets expand treatment options in patients with depression. Ther Deliv. 2011;2(5):611–622. doi:10.4155/tde.11.32
  • Fields J, Go JT, Schulze KS. Pill properties that cause dysphagia and treatment failure. Curr Ther Res Clin Exp. 2015;77:79–82. doi:10.1016/j.curtheres.2015.08.002
  • Nativ-Zeltzer N, Bayoumi A, Mandin VP, et al. Validation of the PILL-5: a 5-item patient reported outcome measure for pill dysphagia. Front Surg. 2019;6:43. doi:10.3389/fsurg.2019.00043
  • Xtampza ER Label. FDA. 2016. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208090s000lbl.pdf. Accessed January 26, 2020.
  • Lee YH, Brown DL, Chen HY. Current impact and application of abuse-deterrent opioid formulations in clinical practice. Pain Physician. 2017;20(7):E1003–E1023.
  • Stanos SP, Bruckenthal P, Barkin RL. Strategies to reduce the tampering and subsequent abuse of long-acting opioids: potential risks and benefits of formulations with physical or pharmacologic deterrents to tampering. Mayo Clin Proc. 2012;87(7):683–694. doi:10.1016/j.mayocp.2012.02.022
  • Maincent J, Zhang F. Recent advances in abuse-deterrent technologies for the delivery of opioids. Int J Pharm. 2016;510(1):57–72. doi:10.1016/j.ijpharm.2016.06.012
  • Hays RD, Spritzer KL, Schalet BD, Cella D. PROMIS((R))-29 v2.0 profile physical and mental health summary scores. Qual Life Res. 2018;27(7):1885–1891. doi:10.1007/s11136-018-1842-3
  • Dysphagia Questionnaire. Centers BASM, ed
  • Hurst H, Bolton J. Assessing the clinical significance of change scores recorded on subjective outcome measures. J Manipulative Physiol Ther. 2004;27(1):26–35. doi:10.1016/j.jmpt.2003.11.003
  • Forough AS, Lau ET, Steadman KJ, et al. A spoonful of sugar helps the medicine go down? A review of strategies for making pills easier to swallow. Patient Prefer Adherence. 2018;12:1337–1346. doi:10.2147/PPA.S164406
  • Roydhouse JK, Fiero MH, Kluetz PG. Investigating potential bias in patient-reported outcomes in open-label cancer trials. JAMA Oncol. 2019;5(4):457–458. doi:10.1001/jamaoncol.2018.6205